Ascendis Pharma A (ASND) Assets Average (2017 - 2025)
Ascendis Pharma A (ASND) has disclosed Assets Average for 6 consecutive years, with $1.4 billion as the latest value for Q4 2025.
- Quarterly Assets Average rose 29.23% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 29.23% year-over-year, with the annual reading at $1.4 billion for FY2025, 29.23% up from the prior year.
- Assets Average hit $1.4 billion in Q4 2025 for Ascendis Pharma A, up from $1.1 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $1.4 billion in Q4 2025 to a low of $1.0 billion in Q4 2023.
- Historically, Assets Average has averaged $1.2 billion across 4 years, with a median of $1.1 billion in 2022.
- Biggest five-year swings in Assets Average: decreased 15.0% in 2023 and later increased 29.23% in 2025.
- Year by year, Assets Average stood at $1.2 billion in 2022, then fell by 15.0% to $1.0 billion in 2023, then grew by 7.43% to $1.1 billion in 2024, then rose by 29.23% to $1.4 billion in 2025.
- Business Quant data shows Assets Average for ASND at $1.4 billion in Q4 2025, $1.1 billion in Q4 2024, and $1.0 billion in Q4 2023.